FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to an antidiabetic composition. Said composition for diabetes treatment contains pioglitazone hydrochloride as an active substance and lactose, microcrystalline cellulose, oxypropylcellulose, sodium croscarmellose, aerosil and stearic acid salt as additives. Preferentially, the composition is tableted; each tablet contains the active substance in amount 15 mg, 30 mg or 45 mg (per pioglitazone).
EFFECT: offered composition is resolved quickly (1-2 minutes and less), easily release the active component (95-100% of pioglitazone passes into a dissolution medium 30 minutes later), is characterised by high breaking strength and abrasion resistance, storage stability of quality level that ensures effective life for 2 years and more.
6 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF ANTIEPILEPTIC ACTIVITY AND METHOD OF PRODUCTION THEREOF | 2007 |
|
RU2345777C1 |
| SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
| PHARMACEUTICAL COMPOSITION ELICITING ANTICONVULSANT AND PSYCHOTROPIC EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240798C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC ACTION | 2009 |
|
RU2420304C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2423981C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTIMIGRAINE ACTION (VERSIONS) | 2008 |
|
RU2424803C2 |
| SOLID MEDICINAL FORMULATION POSSESSING HISTAMINE-LIKE EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2308941C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIDEPRESSANT ACTIVITY | 2000 |
|
RU2174391C1 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE | 2019 |
|
RU2781638C2 |
| HYPOTENSIVE MEDICINAL AGENT | 2006 |
|
RU2317079C1 |
